Related Experiment Video
Updated: Feb 24, 2026

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
High failure rate in Pseudomonas aeruginosa-associated periprosthetic hip and knee joint infections
Ece Akcicek1, Jennyfer A Mitterer1,2, Veronika Achatz1,3
1Michael Ogon Laboratory for Orthopaedic Research, Orthopaedic Hospital Speising, Vienna, Austria.
Abstract:
Introduction: Pseudomonas aeruginosa is one of the most common Gram-negative (GN) pathogens in periprosthetic joint infections (PJIs). However, not many data are available on them. This study aimed to evaluate the prevalence of P. aeruginosa in hip and knee PJIs, patient characteristics, types of infection, resistance patterns, treatments, and outcomes. Methods: We retrospectively analyzed culture-positive revision total hip and knee arthroplasties (rTHA and rTKA) from 2008 to 2023. Cases were evaluated according to the International Consensus Meeting (ICM) 2018 and European Bone and Joint Infection Society (EBJIS) criteria 2021. The success rate was calculated according to Tier classification. Results: Among 1640 revision procedures performed on 1286 patients, 195 revisions in 160 patients were positive for GN microorganisms, including 50 P. aeruginosa cases (3.1 %, hip/knee: 39/11) in 38 patients. Most were chronic (64 %), monomicrobial (74 %) infections, particularly infected rTHA (63.8 %). Proteus mirabilis was the main co-pathogen (23.1 %) in polymicrobial infections. The mean follow-up time was 65.4 months. The most frequent surgical intervention was two-stage exchange (48 %). Chronic infections required significantly more total revisions than acute cases. Success rates decreased with each additional revision. Antibiotic resistance developed in three patients during subsequent revisions. The overall success rate was 46 %. Reinfection-free survival decreased from 95 % at 12 months to 22.4 % after 10 years. Conclusion: In our patient cohort, Pseudomonas aeruginosa accounted for one-third of hip and knee GN PJIs, was mostly found in infected rTHA, and was monomicrobial. Changes in antimicrobial resistance, high failure rates, and low long-term infection-free survival underline that Pseudomonas aeruginosa is a challenging PJI pathogen.
Insights
Pseudomonas aeruginosa is a common cause of Gram-negative periprosthetic joint infections (PJIs), particularly in hip revisions. This pathogen presents challenges with high failure rates and low long-term survival.
Area of Science:
- Orthopedics
- Infectious Diseases
- Microbiology
Background:
- * Pseudomonas aeruginosa is a significant Gram-negative pathogen in periprosthetic joint infections (PJIs).
- * Limited data exist regarding P. aeruginosa's specific role and outcomes in hip and knee PJIs.
Purpose of the Study:
- * To evaluate the prevalence of P. aeruginosa in hip and knee PJIs.
- * To analyze patient characteristics, infection types, antimicrobial resistance, treatments, and outcomes associated with P. aeruginosa PJIs.
Main Methods:
- * Retrospective analysis of culture-positive revision total hip and knee arthroplasties (rTHA and rTKA) from 2008-2023.
- * Evaluation based on International Consensus Meeting (ICM) 2018 and European Bone and Joint Infection Society (EBJIS) 2021 criteria.
- * Success rate calculation using Tier classification.
Main Results:
- * P. aeruginosa was identified in 3.1% of GN PJIs (50 cases), predominantly in hip revisions (63.8%).
- * Infections were mostly chronic (64%), monomicrobial (74%), with Proteus mirabilis as a common co-pathogen (23.1%).
- * Overall success rate was 46%, with decreasing success and reinfection-free survival after multiple revisions.
Conclusions:
- * P. aeruginosa is a prevalent pathogen in hip and knee GN PJIs, often presenting as a monomicrobial chronic infection.
- * High failure rates and evolving antimicrobial resistance highlight P. aeruginosa as a challenging PJI pathogen.
- * P. aeruginosa PJIs require specific management strategies due to poor long-term outcomes.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Acute Pyelonephritis II: Diagnostic Studies and Management

